Generic drugs key to U.S.-suported HIV relief

The President’s Emergency Plan for AIDS Relief (PEPfAR) program has spent billions of dollars during the last nine years to provide HIV-related care to millions of people in 15 developing nations. Had the program not overcome a late start in adopting generic drugs, it would never have accomplished that scale of benefit, write Brown University researchers in the journal Health Affairs.